BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2019
View Archived Issues
Cyclacel Pharmaceuticals initiates phase I study of CYC-065 plus venetoclax in patients with CLL
Read More
Motor protein myosin drives metastasis
Read More
Protein links sleep and sickness
Read More
SGL-5213 demonstrates efficacy in preclinical model of impaired glucose tolerance
Read More
Novel GPR40 superagonist demonstrates remarkable preclinical efficacy in models of diabetes
Read More
Preclinical data presented on PBK-001 vaccine for the treatment of melioidosis
Read More
Tripartite motif family-like 2 downregulation reduces oral squamous cell carcinoma growth
Read More
CSIC patents new PDE8A inhibitors
Read More
FDA issues complete response letter for ALKS-5461 NDA for adjunctive treatment of MDD
Read More
GenSight announces 48-week data from RESCUE trial of GS-010 in LHON
Read More
Dart NeuroScience discloses PDE7B inhibitors
Read More
Oxford University signs option agreement with Blue Water Vaccines for universal influenza vaccine
Read More
Roche and Genentech identify RIP-1 inhibitors
Read More
Nerviano Medical Sciences synthesizes choline kinase inhibitors
Read More
Medshine Discovery presents Rho kinase inhibitors
Read More
Phosphorylation study gives insights into Chlamydia
Read More
OncoSec updates clinical progress with Tavo
Read More
Moderna exercises option for exclusive licensing agreement with Avacta
Read More
Tinagl1 protein may be therapeutic in triple-negative breast cancer
Read More
Circulating miR-3659 found useful for diagnosing dyslipidemia in patients with obesity
Read More
FDA clears IND for phase I/IIa trial of VLPM-01 malaria vaccine
Read More
BREEZE-AD1 and AD2 studies of baricitinib in atopic dermatitis meet primary endpoints
Read More
Eisai plans single phase III confirmatory study of BAN-2401 in early Alzheimer's
Read More
Biohaven plans to advance BHV-3500 into phase II for acute treatment of migraine
Read More
